Oncotarget

Research Papers:

Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma

Irfan A Asangani, Paul W Harms, Lois Dodson, Mithil Pandhi, Lakshmi P Kunju, Christopher A Maher, Douglas R Fullen, Timothy M Johnson, Thomas J Giordano, Nallasivam Palanisamy and Arul M Chinnaiyan _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2012; 3:1011-1025. https://doi.org/10.18632/oncotarget.622

Metrics: PDF 2844 views  |   HTML 2332 views  |   ?  


Abstract

Irfan A. Asangani1,2,*,Paul W. Harms1,2,3,*, Lois Dodson1, Mithil Pandhi1, Lakshmi P. Kunju2, Chris A. Maher1,2,4, Douglas R. Fullen2,3, Timothy M. Johnson3, Thomas J. Giordano2, Nallasivam Palanisamy1,2,5,8, Arul M. Chinnaiyan1,2,5,6,7,8

1 Michigan Center for Translational Pathology

2 Department of Pathology, University of Michigan

3 Department of Dermatology, University of Michigan

4 Center for Computational Medicine and Bioinformatics

5 Comprehensive Cancer Center, University of Michigan Medical School

6 Howard Hughes Medical Institute, University of Michigan Medical School

7 Department of Urology, University of Michigan

8 Shared senior authors

* These authors contributed equally to this work

Correspondence:

Arul M. Chinnaiyan, email:

Keywords: : microRNA-31, melanoma, tumor suppressor, EZH2, DZNep

Received: August 15, 2012, Accepted: August 28, 2012, Published: August 31, 2012

Abstract

MicroRNAs (miRs) play a key role in cancer etiology by coordinately repressing numerous target genes involved in cell proliferation, migration and invasion. The genomic region in chromosome 9p21 that encompasses miR-31 is frequently deleted in solid cancers including melanoma; however the expression and functional role of miR-31 has not been previously studied in melanoma. Here, we queried the expression status and performed functional characterization of miR-31 in melanoma tissues and cell lines. We found that down-regulation of miR-31 was a common event in melanoma tumors and cell lines and was associated with genomic loss in a subset of samples. Down-regulation of miR-31 gene expression was also a result of epigenetic silencing by DNA methylation, and via EZH2-mediated histone methylation. Ectopic overexpression of miR-31 in various melanoma cell lines inhibited cell migration and invasion. miR-31 targets include oncogenic kinases such as SRC, MET, NIK (MAP3K14) and the melanoma specific oncogene RAB27a. Furthermore, miR-31 overexpression resulted in down-regulation of EZH2 and a de-repression of its target gene rap1GAP; increased expression of EZH2 was associated with melanoma progression and overall patient survival. Taken together, our study supports a tumor suppressor role for miR-31 in melanoma and identifies novel therapeutic targets.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 622